The pan-PPAR agonist lanifibranor improves markers of cardiometabolic health in patients with NASH independent of weight change

Cooreman, M; Francque, S; Baudin, M; Huot-Marchand, P; Dzen, L; Junien, JL; Broqua, P; Abdelmalek, M

JOURNAL OF HEPATOLOGY, 2022; 77 (): S721

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索